EVARF (Common Stock)
ExchangeOTCQX (US Dollar)
Change (%)0.00 (NaN%)
Data as of 07/04/19 8:05 p.m. ET
Refresh quote
Data provided by Nasdaq. Minimum 15 minutes delayed.

Lombard Medical, Inc. is a medical device company focused on the $1.8bn market for minimally invasive treatment of abdominal aortic aneurysms (AAAs). The Company has global regulatory approval for Aorfix™, an endovascular stent graft which has been specifically designed to treat patients with the broadest range of AAA anatomies, including aortic neck angulation up to 90 degrees. The Company has also achieved CE Mark for the Altura™ endograft system, an innovative ultra-low profile endovascular stent graft that offers a simple and predictable solution for the treatment of more standard AAA anatomies.

Lombard Medical is based in Oxfordshire, UK.

Lombard Medical's shares trade on the OTCQX Market under the symbol EVARF.

Recent News

10/31/17Lombard Medical Reports First Half and Third Quarter 2017 Financial ResultsPrinter Friendly Version
10/30/17Lombard Medical Announces Shares to Trade on OTCQXPrinter Friendly Version
09/26/17Lombard Medical's New Delivery System for Aorfix(TM) Endovascular Aortic Aneurysm Repair System Launched in JapanPrinter Friendly Version

More »

Upcoming Events

There are currently no events scheduled.

More »